Coastlines was initially approached to create a new annual report for Forbes, a pharmaceutical company specializing in treatment and prevention of cardiovascular diseases. Our approach was to create a piece that focused on the ´human aspect´ and overall benefits their novel science has to offer.
Components included creative direction, photoshoots, type treatments and new colour palettes. These were introduced to interactive, collateral materials, exhibits, direct mail and Web site. Ongoing, Coastlines has produced four concurrent international award winning annual reports for the company.
Other initiatives have included branding their nutraceutical product ´Reducol™´ to both healthcare professionals, strategic partners and consumers in
North America and Europe.
www.forbesmedi.com
www.reducol.com